Donepezil hydrochloride in the treatment of senile Alzheimer's disease, early stage
| dc.contributor.author | Berezhna, A. | |
| dc.contributor.author | Reznichenko, E. | |
| dc.contributor.author | Pavlova, O. | |
| dc.date.accessioned | 2014-11-23T18:35:57Z | |
| dc.date.available | 2014-11-23T18:35:57Z | |
| dc.date.issued | 2014-05-15 | |
| dc.description.abstract | We observed five patients aged 75 to 82 years, two women and three men. Memory loss, impaired concentration, mild depression was observed in all patients. Based on clinical and paraclinical methods was diagnosed Senile Alzheimer's disease early stage. In the combined therapy was appointed donepezil hydrochloride ("Alzepil") at a dose of 5 mg at bedtime for 3 months. | uk_UA |
| dc.identifier.citation | Berezhna A. V. Donepezil hydrochloride in the treatment of senile Alzheimer's disease, early stage / A. V. Berezhna, E. K. Reznichenko, O. S. Pavlova // 7th International Scientific Interdisciplinary Conference (ISIC) for medical students and young scientists, Kharkiv, May 15–16, 2014 : abstract book / KhNMU. – Kharkiv, 2014. – P. 226. | uk_UA |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/7863 | |
| dc.language.iso | en | uk_UA |
| dc.publisher | Kharkiv National Medical University | uk_UA |
| dc.subject | alzheimer’s disease | uk_UA |
| dc.subject | dementia | uk_UA |
| dc.subject | donepezil hydrochloride | uk_UA |
| dc.title | Donepezil hydrochloride in the treatment of senile Alzheimer's disease, early stage | uk_UA |
| dc.type | Thesis | uk_UA |